We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Futura Medical Plc | LSE:FUM | London | Ordinary Share | GB0033278473 | ORD 0.2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-1.90 | -5.45% | 32.95 | 33.00 | 33.85 | 34.75 | 32.95 | 34.25 | 584,830 | 16:20:06 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -5.85M | -0.0194 | -16.98 | 99.08M |
Date | Subject | Author | Discuss |
---|---|---|---|
20/6/2023 15:14 | US deals coming soon | j777j | |
20/6/2023 15:09 | All the time he spends committing fraud on the boots.com website doesn't seem to effect the share price lollll Just filter the broke nutjob ;-) | broomrigg | |
20/6/2023 15:08 | Fun to watch tbh. Surprised he's still here. | babbler | |
20/6/2023 14:56 | You need to filter the new one, too. He got bored talking to himself. | joestalin | |
20/6/2023 14:47 | Heading towards 100p minimum | losses | |
20/6/2023 14:41 | LBO getting shafted using errexon ! | losses | |
20/6/2023 14:13 | Futura on the constant gainers page.....EIGHT DAYS of consecutive gains :-) | broomrigg | |
18/6/2023 09:40 | Will be interesting how the yanks will react to being sold an inert placebo for 25 quid (or maybe north of 35 dollars) with possible overwhelming damning reviews in line with the current Boots. In the "land of litigation" it will be very interesting indeed. | thebutler | |
18/6/2023 04:42 | Pet, I used to think you were tuppence short of a shilling... | glavey | |
17/6/2023 10:27 | Well well well. LiarBOoth has changed his tactics (and names, again!). He obviously realised that his multi-ID ring was beyond ridiculous since I kept pulling him up on it, so he decided to disconnect from the old LBO, (subscribed member) wipe his profile off completely, and start again with an old free membership with the name of LBO1. At least, that's what he wants everyone to think. In reality, he's got a string of other dormant free memberships that he probably planned to unleash if the share price had rocketed with the FDA announcement. Here's a few that I've gleaned: ih_661145 innocmagbal1977 Member since: 18 Feb 2018 ih_662296 cribamprofsi1972 Member since: 19 Feb 2018 ih_661100 inlutita1973 Member since: 18 Feb 2018 lh_101377 Fidellio Member since: 21 May 2007 There are plenty more, they all 'follow' each other and have one thing in common - none of them have ever posted on here. If you think this is yet more skullduggery from the lying stock basher, report it to ADVFN moderators. They won't do anything though, they seem to be complicit with LiarBOoth's actions, so do as Martin Elwick suggested - use LSE for FUM share chat. I've been banging that drum for years, it's far superior chat there, and they had the integrity to ban LiarBOoth. | petroc | |
16/6/2023 22:29 | Update on US commercialisation in 'due course', investor day next week, increasing Eroxon sales = opportunity for success. And the best opportunity success brings is the opportunity for more success. Simples! | k8 rhm | |
16/6/2023 20:37 | It is surely the case that no one is really interested in this BB apart from liarbooth.The worry about him trashing the product and needing to respond is so over stated. Can I recommend that you only use this site to get the share price. Don't trouble to look at the BB. Head over to LSE, where there is lots of informative discussion. Leave LB in a vacuum.It will drive him insane!!! | martinelwick | |
16/6/2023 16:08 | Thanks for the link Keifer. Sales are looking VERY strong. Just checked Amazon UK and the Eroxon product page has been updated to "2K+ bought in past week" (had been at 1K+ sales per week for some time). I was sat watching Sky News last night and at around 8pm the Eroxon advert was shown. | broomrigg |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions